Marine-derived Pharmaceuticals Market
Marine-derived Pharmaceuticals Market is Focusing on the Key Segments, which are Drug Type, Source, Sales Channel and Region - Global Market Insights 2023 to 2033
Analysis of Marine-derived Pharmaceuticals Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Marine-derived Pharmaceuticals Market Outlook (2023 to 2033)
The market for pharmaceuticals derived from marine sources is anticipated to grow from US$ 4,131.3 million in 2023 to US$ 9,083.1 million in 2033. Global sales of pharmaceuticals derived from marine sources are predicted to increase at a CAGR of 8.2% over the ensuing ten years (2023 - 2033).
Attributes |
Key Insights |
|---|---|
|
Estimated Global Marine-derived Pharmaceuticals Market Size (2023E) |
US$ 4,131.3 million |
|
Projected Marine-derived Pharmaceuticals Market Value (2033F) |
US$ 9,083.1 million |
|
Value-based CAGR (2023 to 2033) |
8.2% |
|
Top 3 Countrie’s Value |
US$ 1,499.7 million |
|
Top 3 Countrie’s Share |
36.3% |
Key Trends Listed by Fact.MR :
- Use of marine ingredients to manufacture multiple products across various industries, cosmetics, and food and beverage due to their medicinal properties have caught the attention of the medical community
- Technological advancements in the field of medicine have helped the industry tap into multiple alternatives such as sourcing ingredients from marine sources that provide greater promise in the long run
- There is a growing inclination and interest toward the potential of marine microbes in the field of medicine to produce novel drugs and supplements
- Several marine-derived by-products like Ara-A, didemnins, Patellazole B have antiviral properties and can be used in the field of medicine to formulate drugs, medicines, and dietary supplements
- Marine-derived pharmaceuticals are used as sources of chemical diversity in drug discovery programs
- Marine biotechnology is an emerging field and plays a fundamental role in the formulation of new pharmaceutical products
- Pharmaceutical companies are increasingly reviewing multiple marine sources in search of active ingredients
- Today, with the use of multiple modern tools in the field of molecular biology and advanced technology the potential of marine by-products can be harnessed to formulate Marine-derived pharmaceuticals
- Marine organisms provide a vast reservoir of natural and original molecules that can be used to treat life-threatening diseases like cancer and other disorders
- Marine-derived chemicals have the potential to act as key alternatives to exhaustible resources in the pharmaceutical industry as many marine by-products hold anti-inflammatory, anticancer, antiviral, and antibacterial properties
- Marine compounds that can be farmed or grown in order to yield valuable compounds hold potential in the pharmaceutical and medical industry
One of the most abundant sources of valuable chemical compounds is marine sponges. There are ~15,000 natural Marine-derived products that have the potential to be used in the pharmaceutical and medical industry and ~30% of them are isolated from marine sponges. Sponges produce a wider variety of chemical structures than any other known species of marine organisms.
Additionally, marine sponges is a specie that is available in all water bodies. There are species of marine sponges like Disidea avara that inhabit immunodeficiency virus and have therapeutic properties. Bryozoans, which is known best for their potential to be used as an anti-cancer drug. Other products like mollusks, cnidarians, and algae also hold potential.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
2018 to 2022 Global Marine-derived Pharmaceuticals Sales Outlook Compared to Demand Forecast from 2023 to 2033
According to the Fact.MR analysis, global Marine-derived Pharmaceuticals sales grew at a CAGR of 7.5% from 2018 to 2022. For the next ten years, the worldwide market for Marine-derived Pharmaceuticals is forecast to progress at 8.2% CAGR.
In recent years there has been an increase in the inclination of the medical industry to look for alternatives to conventional sources of chemical compounds that can be used to formulate and manufacture drugs and medications that cater to a specific deficiency. There has been a growing interest in the potential of ocean bodies to be the home of multiple bioactive compound alternatives. To harness the potential of marine biotechnology in pharmaceutical and medical science developing an understanding of genetics is necessary.
Marine by-products and marine sources should be used to formulate drugs and medications for tropical infections and chronic diseases that modern-day medications and supplements are not able to cure. Additionally, due to the abundance of marine resources, the easy availability of raw materials will help manufacturers lower the price of medications which will help in the eradication of epidemics from the lower middle class and lower sections of society.
Attention should be paid to the development of pharmaceuticals from marine sources considering the advances made in the field of biotechnology and discoveries made in terms of novel marine compounds that can be used to formulate effective and natural drugs and medicines. Marine sources have shown potential in the treatment of cancer, infectious diseases, and disorders.
Adjacent Markets Overview :
Dietary Supplements :
| Attributes | Dietary Supplements |
|---|---|
|
CAGR (2023 to 2033) |
8.7% |
|
Market Value (2033) |
~US$ 140,005.7 million |
|
Growth Factor |
Preventive health is better than treatment. Modern-day consumers are more cautious about their health and wellness and hence are more inclined towards regular consumption of supplements to meet their daily nutritional requirements. |
|
Opportunity |
Increasing lifestyle diseases among consumers due to hectic lifestyle patterns have prompted consumers to take preventive measures to lead a healthy life. This provides manufacturers with the ability to formulate supplements that are easy to consume on a daily basis and have lesser side effects. |
|
Key Trends |
Clean Label Trend Gaining Traction - According to the Food Insider Journal, 75% of consumers are willing to pay extra for clean-label ingredients. |
Oral Clinical Nutrition Supplement :
| Attributes | Oral Clinical Nutrition Supplement |
|---|---|
|
CAGR (2023 to 2033) |
6.2% |
|
Market Value (2033) |
~US$ 17,450.2 million |
|
Growth Factor |
There is an increase in the awareness of oral clinical nutritional supplements in youngsters as oral clinical nutrition supplements provide nutrients, including protein and energy. |
|
Opportunity |
The rise in diseases like malnutrition, diabetes, and other vitamin and mineral deficiencies have given rise to the need for oral supplements to be taken on a daily basis. |
|
Key Trends |
Increase in the attention towards personal health and a nutritionally balanced diet, and increased healthcare spending. |
Plant-based iron Supplements Market :
| Attributes | Plant-based iron Supplements Market |
|---|---|
|
CAGR (2023 to 2033) |
6.1% |
|
Market Value (2033) |
~US$ 355.6 million |
|
Growth Factor |
Demand for organic products in the global market and support by local companies for the development of natural products is expected to drive the growth of the market. |
|
Opportunity |
Government support towards plant-based alternatives has added to the demand for plant-based iron supplements in the market. Governments of various regions are also supporting the formulation of plant-based alter. |
|
Key Trends |
There is a rise in demand for supplements that cater to a specific deficiency like iron deficiency, vitamin B12 deficiency, and more and hence there is a growing trend of nutrition-specific supplements in the market. |
Country-wise Insights :
North America - CAGR
| Country | CAGR (%) |
|---|---|
| United States | 7.2% |
Europe - CAGR
| Country | CAGR (%) |
|---|---|
| United Kingdom | 5.6% |
Asia Pacific - CAGR
| Country | CAGR (%) |
|---|---|
| China | 5.6% |
| India | 6.5% |
| Japan | 6.8% |
North America - BPS Analysis
| Country | BPS Analysis |
|---|---|
| United States | 90 |
Europe - BPS Analysis
| Country | BPS Analysis |
|---|---|
| United Kingdom | -50 |
Asia Pacific - BPS Analysis
| Country | BPS Analysis |
|---|---|
| China | 60 |
| India | 180 |
| Japan | -20 |
North America - Market Value (2033)
| Country | Market Value (2033) |
|---|---|
| United States | US$ 1,925.6 million |
Europe - Market Value (2033)
| Country | Market Value (2033) |
|---|---|
| United Kingdom | US$ 890.2 million |
Asia Pacific - Market Value (2033)
| Country | Market Value (2033) |
|---|---|
| China | US$ 572.2 million |
| India | US$ 499.6 million |
| Japan | US$ 227.1 million |
China is committed to the marine-derived pharmaceutical industry and its efforts to harness the potential of marine resources for drug discovery and development.
As per Fact.MR, China’s Marine-derived Pharmaceuticals market is expected to reach a valuation of around US$ 599.5 million by 2033.
China has a vast coastline covering ~14,500 kilometers and is home to a diverse range of marine habitats and ecosystems. Its vast biodiversity includes various species of marine organisms like algae, microorganisms, and invertebrates that possess a bioactive compounds that hold a strong potential in the pharmaceutical industry.
China’s regulatory framework for marine-derived pharmaceuticals has evolved with innovation and ensures safety and quality. The China Food and Drug Administration (CFDA) regulates the pharmaceuticals in the country. It has set specific guidelines for marine-derived drugs that ensure compliance and safety standards.
China is also known to actively collaborate with other countries in international marine research projects. In 2022, there were 15 marine-derived drugs approved by the FDA of which one was approved in China and the rest in Australia.
Demand Outlook for the Marine-derived Pharmaceuticals in India Market
India has immense potential due its rich marine biodiversity and is investing heavily in research related to the potential of Marine-derived sources in pharmaceutical and medical industry
Marine-derived Pharmaceuticals demand in India is anticipated to rise at a steady CAGR of 6.5% during the forecast period from 2023 to 2033 and is expected to reach a market valuation of US$ 499.6 Mn by 2033.
India has a huge market for animal feed. Marine algae such as seaweeds hold a lot of potential as ingredients in animal feed. Algae are rich in nutrients like proteins, vitamins and minerals and are also a good source of bioactive compounds which are very useful in the pharmaceutical sector. Algae are also easy to be cultivated and farmed in coastal regions or offshore waters providing a sustainable and renewable source of feed alternatives
In India, manufacturers have increased their focus on sustainable sourcing of raw materials. Alternatives like seaweed and microalgae hold potential. Additionally, making use of by-products formed in the fish processing industry also help in minimizing the pollution and degradation of water bodies.
Which is the Most Sought-after Drug Type in the Market?
Demand in the Market to Remain High for Fish Meal Marine-derived Pharmaceuticals
One of the most valuable and sought-after drug types that can be derived from marine sources is anti-cancer drugs. Cancer is a major global health concern today and there is a continuous need for effective treatment of the same. Marine organisms are a valuable source of bioactive compounds which hold anti-cancer properties. Some marine-derived compounds have specific properties that inhibit tumour growth and recurrence.
Marine sources are also known to have anti-inflammatory, neuroprotective properties as a result of which they hold potential in the medical and pharmaceutical industry. The marine-derived pharmaceutical industry is continuously evolving with increasing investment in research and development in exploring the therapeutic potential of marine resources.
Why is Demand for Marine Sponges in Marine-derived Pharmaceuticals Rising Globally?
Marine sponges are a good source of bioactive compounds, including alkaloids, peptides, terpenoids, polyketides, and sterols.
Marine sponges are a rich source of bioactive compounds with diverse chemical structures and potent pharmacological activities. Many compounds derived from marine sponges have a wide range of pharmacological activities, such as anticancer, antiviral, neuroprotective, and antimicrobial. These diverse activities make marine sponge-derived compounds a valuable source for the pharmaceutical industry with a wide range of therapeutic applications.
Moreover, marine sponges can be farmed sustainably, ensuring minimal impact on the marine ecosystem which makes them an environmentally friendly source of bioactive compounds.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Competitive Landscape :
The competitive landscape of Marine-derived Pharmaceuticals is dynamic and constantly evolving as the demand for sustainable and cost-effective options continues to grow. Several factors influence the competitiveness of Marine-derived Pharmaceuticals, and nutritional value, including availability, cost, and regulatory considerations.
Scope of the Report :
Attribute |
Details |
|---|---|
|
Market Size Value in 2023 |
US$ 4,131.3 million |
|
Market Forecast Value in 2033 |
US$ 9,083.1 million |
|
Anticipated Growth Rate (2023 to 2033) |
8.2% CAGR |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2018 to 2022 |
|
Market Analysis |
|
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Marine-derived Pharmaceuticals Market by Category :
-
By Drug Type :
- Antibacterial
- Anti-inflammatory
- Neuroprotective
- Antiviral agent
- Anticancer
- Analgesic
- Antimicrobial
-
By Source :
- Algae
- Tunicate/Ascidiacea
- Marine Sponges
- Actinomyces
- Mollusc
- Bryoza
- Shark Cartilage
- Marine Fungi
- Soft Corals
-
By Sales Channel :
- Prescription Based
- Over the Counter
- Drug Stores
- Pharmacies
- Retail Stores
- Online Merchandizers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition 3. Market Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends By Region 3.5. Forecast Factors - Relevance & Impact 3.6. Key Regulations and Policies 4. Value Chain Analysis 4.1. Operating margins at each node of the supply chain 4.2. List of Active Market Participants 5. Global - Pricing Analysis 5.1. Price Point Assessment by Region 5.1.1. Manufacturer-Level Pricing 5.1.2. Distributor Level Pricing 5.2. Price Point Assessment By Product 5.3. Price Forecast till 2033 6. Global Market Size (in Value (US$ million) and Volume (MT) Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis, 2018 to 2022 6.2. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Type 7.1. Introduction / Key Findings 7.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Drug Type, 2018 to 2022 7.3. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Drug Type, 2023 to 2033 7.3.1. Antibacterial 7.3.2. Anti-inflammatory 7.3.3. Neuroprotective 7.3.4. Antiviral agent 7.3.5. Anticancer 7.3.6. Analgesic 7.3.7. Antimicrobial 7.4. Market Attractiveness Analysis By Drug Type 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source 8.1. Introduction / Key Findings 8.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Source, 2018 to 2022 8.3. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Source, 2023 to 2033 8.3.1. Algae 8.3.2. Tunicate/Ascidiacea 8.3.3. Marine Sponges 8.3.4. Actinomyces 8.3.5. Mollusc 8.3.6. Bryoza 8.3.7. Shark Cartilage 8.3.8. Marine Fungi 8.3.9. Soft Corals 8.4. Market Attractiveness Analysis By Source 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sales Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Sales Channel, 2018 to 2022 9.3. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Sales Channel, 2023 to 2033 9.3.1. Prescription Based 9.3.2. Over the Counter 9.3.3. Drug Stores 9.3.4. Pharmacies 9.3.5. Retail Stores 9.3.6. Online Merchandizers 9.4. Market Attractiveness Analysis By Sales Channel 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 10.1. Introduction 10.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Region, 2018 to 2022 10.3. Current Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East & Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 11.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 11.3.1. By Country 11.3.1.1. US 11.3.1.2. Canada 11.3.2. By Drug Type 11.3.3. By Source 11.3.4. By Sales Channel 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Drug Type 11.4.3. By Source 11.4.4. By Sales Channel 11.5. Key Takeaways 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 12.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. By Drug Type 12.3.3. By Source 12.3.4. By Sales Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. Form 12.4.3. By Source 12.4.4. By Sales Channel 12.5. Key Takeaways 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 13.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. UK 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Nordic 13.3.1.8. Russia 13.3.1.9. Poland 13.3.1.10. Rest of Europe 13.3.2. By Drug Type 13.3.3. By Source 13.3.4. By Sales Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Drug Type 13.4.3. By Source 13.4.4. By Sales Channel 13.5. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 14.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Drug Type 14.3.3. By Source 14.3.4. By Sales Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Drug Type 14.4.3. By Source 14.4.4. By Sales Channel 14.5. Key Takeaways 15. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 15.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Malaysia 15.3.1.4. Indonesia 15.3.1.5. Singapore 15.3.1.6. Vietnam 15.3.1.7. Philippines 15.3.1.8. Rest of South Asia 15.3.2. By Drug Type 15.3.3. By Source 15.3.4. By Sales Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Drug Type 15.4.3. By Source 15.4.4. By Sales Channel 15.5. Key Takeaways 16. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 16.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Drug Type 16.3.3. By Source 16.3.4. By Sales Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Drug Type 16.4.3. By Source 16.4.4. By Sales Channel 16.5. Key Takeaways 17. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 17.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Turkey 17.3.1.3. Egypt 17.3.1.4. South Africa 17.3.1.5. Rest of MEA 17.3.2. By Drug Type 17.3.3. By Source 17.3.4. By Sales Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Drug Type 17.4.3. By Source 17.4.4. By Sales Channel 17.5. Key Takeaways 18. Country-level Market Analysis, 2023 18.1. United States Market Analysis 18.1.1. By Drug Type 18.1.2. By Source 18.1.3. By Sales Channel 18.2. Canada Market Analysis 18.2.1. By Drug Type 18.2.2. By Source 18.2.3. By Sales Channel 18.3. Brazil Market Analysis 18.3.1. By Drug Type 18.3.2. By Source 18.3.3. By Sales Channel 18.4. Mexico Market Analysis 18.4.1. By Drug Type 18.4.2. By Source 18.4.3. By Sales Channel 18.5. Argentina Market Analysis 18.5.1. By Drug Type 18.5.2. By Source 18.5.3. By Sales Channel 18.6. Germany Market Analysis 18.6.1. By Drug Type 18.6.2. By Source 18.6.3. By Sales Channel 18.7. United Kingdom Market Analysis 18.7.1. By Drug Type 18.7.2. By Source 18.7.3. By Sales Channel 18.8. France Market Analysis 18.8.1. By Drug Type 18.8.2. By Source 18.8.3. By Sales Channel 18.9. Italy Market Analysis 18.9.1. By Drug Type 18.9.2. By Source 18.9.3. By Sales Channel 18.10. Spain Market Analysis 18.10.1. By Drug Type 18.10.2. By Source 18.10.3. By Sales Channel 18.11. Belgium Market Analysis 18.11.1. By Drug Type 18.11.2. By Source 18.11.3. By Sales Channel 18.12. Netherlands Market Analysis 18.12.1. By Drug Type 18.12.2. By Source 18.12.3. By Sales Channel 18.13. Nordic Market Analysis 18.13.1. By Drug Type 18.13.2. By Source 18.13.3. By Sales Channel 18.14. Russia Market Analysis 18.14.1. By Drug Type 18.14.2. By Source 18.14.3. By Sales Channel 18.15. Poland Market Analysis 18.15.1. By Drug Type 18.15.2. By Source 18.15.3. By Sales Channel 18.16. China Market Analysis 18.16.1. By Drug Type 18.16.2. By Source 18.16.3. By Sales Channel 18.17. Japan Market Analysis 18.17.1. By Drug Type 18.17.2. By Source 18.17.3. By Sales Channel 18.18. S Korea Market Analysis 18.18.1. By Drug Type 18.18.2. By Source 18.18.3. By Sales Channel 18.19. India Market Analysis 18.19.1. By Drug Type 18.19.2. By Source 18.19.3. By Sales Channel 18.20. Thailand Market Analysis 18.20.1. By Drug Type 18.20.2. By Source 18.20.3. By Sales Channel 18.21. Malaysia Market Analysis 18.21.1. By Drug Type 18.21.2. By Source 18.21.3. By Sales Channel 18.22. Vietnam Market Analysis 18.22.1. By Drug Type 18.22.2. By Source 18.22.3. By Sales Channel 18.23. Philippines Market Analysis 18.23.1. By Drug Type 18.23.2. By Source 18.23.3. By Sales Channel 18.24. Indonesia Market Analysis 18.24.1. By Drug Type 18.24.2. By Source 18.24.3. By Sales Channel 18.25. Singapore Market Analysis 18.25.1. By Drug Type 18.25.2. By Source 18.25.3. By Sales Channel 18.26. Australia Market Analysis 18.26.1. By Drug Type 18.26.2. By Source 18.26.3. By Sales Channel 18.27. New Zealand Market Analysis 18.27.1. By Drug Type 18.27.2. By Source 18.27.3. By Sales Channel 18.28. GCC Countries Market Analysis 18.28.1. By Drug Type 18.28.2. By Source 18.28.3. By Sales Channel 18.29. Turkey Market Analysis 18.29.1. By Drug Type 18.29.2. By Source 18.29.3. By Sales Channel 18.30. Egypt Market Analysis 18.30.1. By Source 18.30.2. By Sales Channel 18.31. South Africa Market Analysis 18.31.1. By Drug Type 18.31.2. By Source 18.31.3. By Sales Channel 19. Market Structure Analysis 19.1. Global Competition - a Dashboard View 19.2. Industry Structure Analysis 19.2.1. % tier 1 market players 19.2.2. % tier 2 market players 19.2.3. % tier 3 market players 19.3. Global Market Company Share Analysis 19.3.1. For Tier 1 Market Players, 2023 19.3.2. Company Market Share Analysis of Top 5 Players, By Region 19.4. Key Participants Market Presence (Intensity Mapping) by Region 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Pfizer Inc. 20.3.1.1. Product Portfolio 20.3.1.2. Product Claim 20.3.1.3. Revenue by Market Segments 20.3.1.4. Sales Footprint 20.3.1.5. Strategy Overview 20.3.1.5.1. Marketing Strategy 20.3.1.5.2. Product Strategy 20.3.1.5.3. Channel Strategy 20.3.1.6. SWOT Analysis 20.3.2. TerSera Therapeutics LLC. 20.3.2.1. Product Portfolio 20.3.2.2. Product Claim 20.3.2.3. Revenue by Market Segments 20.3.2.4. Sales Footprint 20.3.2.5. Strategy Overview 20.3.2.5.1. Marketing Strategy 20.3.2.5.2. Product Strategy 20.3.2.5.3. Channel Strategy 20.3.2.6. SWOT Analysis 20.3.3. Janssen Products, LP 20.3.3.1. Product Portfolio 20.3.3.2. Product Claim 20.3.3.3. Revenue by Market Segments 20.3.3.4. Sales Footprint 20.3.3.5. Strategy Overview 20.3.3.5.1. Marketing Strategy 20.3.3.5.2. Product Strategy 20.3.3.5.3. Channel Strategy 20.3.3.6. SWOT Analysis 20.3.4. Eisai Inc. 20.3.4.1. Product Portfolio 20.3.4.2. Product Claim 20.3.4.3. Revenue by Market Segments 20.3.4.4. Sales Footprint 20.3.4.5. Strategy Overview 20.3.4.5.1. Marketing Strategy 20.3.4.5.2. Product Strategy 20.3.4.5.3. Channel Strategy 20.3.4.6. SWOT Analysis 20.3.5. Biotium, 20.3.5.1. Product Portfolio 20.3.5.2. Product Claim 20.3.5.3. Revenue by Market Segments 20.3.5.4. Sales Footprint 20.3.5.5. Strategy Overview 20.3.5.5.1. Marketing Strategy 20.3.5.5.2. Product Strategy 20.3.5.5.3. Channel Strategy 20.3.5.6. SWOT Analysis 20.3.6. PharmaMar 20.3.6.1. Product Portfolio 20.3.6.2. Product Claim 20.3.6.3. Revenue by Market Segments 20.3.6.4. Sales Footprint 20.3.6.5. Strategy Overview 20.3.6.5.1. Marketing Strategy 20.3.6.5.2. Product Strategy 20.3.6.5.3. Channel Strategy 20.3.6.6. SWOT Analysis 20.3.7. Zeltia ZEL.MC 20.3.7.1. Product Portfolio 20.3.7.2. Product Claim 20.3.7.3. Revenue by Market Segments 20.3.7.4. Sales Footprint 20.3.7.5. Strategy Overview 20.3.7.5.1. Marketing Strategy 20.3.7.5.2. Product Strategy 20.3.7.5.3. Channel Strategy 20.3.7.6. SWOT Analysis 20.3.8. High Liner Foods Inc. 20.3.8.1. Product Portfolio 20.3.8.2. Product Claim 20.3.8.3. Revenue by Market Segments 20.3.8.4. Sales Footprint 20.3.8.5. Strategy Overview 20.3.8.5.1. Marketing Strategy 20.3.8.5.2. Product Strategy 20.3.8.5.3. Channel Strategy 20.3.8.6. SWOT Analysis 20.3.9. GFR Pharma 20.3.9.1. Product Portfolio 20.3.9.2. Product Claim 20.3.9.3. Revenue by Market Segments 20.3.9.4. Sales Footprint 20.3.9.5. Strategy Overview 20.3.9.5.1. Marketing Strategy 20.3.9.5.2. Product Strategy 20.3.9.5.3. Channel Strategy 20.3.9.6. SWOT Analysis 20.3.10. Amway Corp. 20.3.10.1. Product Portfolio 20.3.10.2. Product Claim 20.3.10.3. Revenue by Market Segments 20.3.10.4. Sales Footprint 20.3.10.5. Strategy Overview 20.3.10.5.1. Marketing Strategy 20.3.10.5.2. Product Strategy 20.3.10.5.3. Channel Strategy 20.3.10.6. SWOT Analysis 20.3.11. General Mills Inc., 20.3.11.1. Product Portfolio 20.3.11.2. Product Claim 20.3.11.3. Revenue by Market Segments 20.3.11.4. Sales Footprint 20.3.11.5. Strategy Overview 20.3.11.5.1. Marketing Strategy 20.3.11.5.2. Product Strategy 20.3.11.5.3. Channel Strategy 20.3.11.6. SWOT Analysis 20.3.12. Standard Functional Foods Group 20.3.12.1. Product Portfolio 20.3.12.2. Product Claim 20.3.12.3. Revenue by Market Segments 20.3.12.4. Sales Footprint 20.3.12.5. Strategy Overview 20.3.12.5.1. Marketing Strategy 20.3.12.5.2. Product Strategy 20.3.12.5.3. Channel Strategy 20.3.12.6. SWOT Analysis 20.3.13. Abbott Laboratories 20.3.13.1. Product Portfolio 20.3.13.2. Product Claim 20.3.13.3. Revenue by Market Segments 20.3.13.4. Sales Footprint 20.3.13.5. Strategy Overview 20.3.13.5.1. Marketing Strategy 20.3.13.5.2. Product Strategy 20.3.13.5.3. Channel Strategy 20.3.13.6. SWOT Analysis 20.3.14. Roquette Kloetze 20.3.14.1. Product Portfolio 20.3.14.2. Product Claim 20.3.14.3. Revenue by Market Segments 20.3.14.4. Sales Footprint 20.3.14.5. Strategy Overview 20.3.14.5.1. Marketing Strategy 20.3.14.5.2. Product Strategy 20.3.14.5.3. Channel Strategy 20.3.14.6. SWOT Analysis 20.3.15. Rizhao Jiejing 20.3.15.1. Product Portfolio 20.3.15.2. Product Claim 20.3.15.3. Revenue by Market Segments 20.3.15.4. Sales Footprint 20.3.15.5. Strategy Overview 20.3.15.5.1. Marketing Strategy 20.3.15.5.2. Product Strategy 20.3.15.5.3. Channel Strategy 20.3.15.6. SWOT Analysis 20.3.16. Ocean Biotechnol 20.3.16.1. Product Portfolio 20.3.16.2. Product Claim 20.3.16.3. Revenue by Market Segments 20.3.16.4. Sales Footprint 20.3.16.5. Strategy Overview 20.3.16.5.1. Marketing Strategy 20.3.16.5.2. Product Strategy 20.3.16.5.3. Channel Strategy 20.3.16.6. SWOT Analysis 21. Assumptions and Acronyms Used 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2018-2033
Table 02: Global Market Volume (MT) Forecast by Region, 2018-2033
Table 03: Global Market Value (US$ Mn) Forecast by Drug Type, 2018-2033
Table 04: Global Market Volume (MT) Forecast by Drug Type, 2018-2033
Table 05: Global Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 06: Global Market Volume (MT) Forecast by Source, 2018-2033
Table 07: Global Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 08: Global Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 09: North America Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 10: North America Market Volume (MT) Forecast by Country, 2018-2033
Table 11: North America Market Value (US$ Mn) Forecast by Drug Type, 2018-2033
Table 12: North America Market Volume (MT) Forecast by Drug Type, 2018-2033
Table 13: North America Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 14: North America Market Volume (MT) Forecast by Source, 2018-2033
Table 15: North America Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 16: North America Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 17: Latin America Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 18: Latin America Market Volume (MT) Forecast by Country, 2018-2033
Table 19: Latin America Market Value (US$ Mn) Forecast by Drug Type, 2018-2033
Table 20: Latin America Market Volume (MT) Forecast by Drug Type, 2018-2033
Table 21: Latin America Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 22: Latin America Market Volume (MT) Forecast by Source, 2018-2033
Table 23: Latin America Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 24: Latin America Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 25: Europe Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 26: Europe Market Volume (MT) Forecast by Country, 2018-2033
Table 27: Europe Market Value (US$ Mn) Forecast by Drug Type, 2018-2033
Table 28: Europe Market Volume (MT) Forecast by Drug Type, 2018-2033
Table 29: Europe Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 30: Europe Market Volume (MT) Forecast by Source, 2018-2033
Table 31: Europe Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 32: Europe Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 33: East Asia Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 34: East Asia Market Volume (MT) Forecast by Country, 2018-2033
Table 35: East Asia Market Value (US$ Mn) Forecast by Drug Type, 2018-2033
Table 36: East Asia Market Volume (MT) Forecast by Drug Type, 2018-2033
Table 37: East Asia Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 38: East Asia Market Volume (MT) Forecast by Source, 2018-2033
Table 39: East Asia Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 40: East Asia Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 41: South Asia Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 42: South Asia Market Volume (MT) Forecast by Country, 2018-2033
Table 43: South Asia Market Value (US$ Mn) Forecast by Drug Type, 2018-2033
Table 44: South Asia Market Volume (MT) Forecast by Drug Type, 2018-2033
Table 45: South Asia Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 46: South Asia Market Volume (MT) Forecast by Source, 2018-2033
Table 47: South Asia Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 48: South Asia Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 49: Oceania Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 50: Oceania Market Volume (MT) Forecast by Country, 2018-2033
Table 51: Oceania Market Value (US$ Mn) Forecast by Drug Type, 2018-2033
Table 52: Oceania Market Volume (MT) Forecast by Drug Type, 2018-2033
Table 53: Oceania Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 54: Oceania Market Volume (MT) Forecast by Source, 2018-2033
Table 55: Oceania Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 56: Oceania Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 57: MEA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 58: MEA Market Volume (MT) Forecast by Country, 2018-2033
Table 59: MEA Market Value (US$ Mn) Forecast by Drug Type, 2018-2033
Table 60: MEA Market Volume (MT) Forecast by Drug Type, 2018-2033
Table 61: MEA Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 62: MEA Market Volume (MT) Forecast by Source, 2018-2033
Table 63: MEA Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 64: MEA Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 65: Oceania Market Value (US$ Mn) Forecast by Product Type, 2018-2033
Table 66: Oceania Market Volume (MT) Forecast by Product Type, 2018-2033
Table 67: Oceania Market Value (US$ Mn) Forecast by Form, 2018-2033
Table 68: Oceania Market Volume (MT) Forecast by Form, 2018-2033
Table 69: Oceania Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 70: Oceania Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 71: MEA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 72: MEA Market Volume (MT) Forecast by Country, 2018-2033
Table 73: MEA Market Value (US$ Mn) Forecast by Active Compounds, 2018-2033
Table 74: MEA Market Volume (MT) Forecast by Active Compounds, 2018-2033
Table 75: MEA Market Value (US$ Mn) Forecast by Product Type, 2018-2033
Table 76: MEA Market Volume (MT) Forecast by Product Type, 2018-2033
Table 77: MEA Market Value (US$ Mn) Forecast by Form, 2018-2033
Table 78: MEA Market Volume (MT) Forecast by Form, 2018-2033
Table 79: MEA Market Value (US$ Mn) Forecast by Sales Channel, 2018-2033
Table 80: MEA Market Volume (MT) Forecast by Sales Channel, 2018-2033
Table 81: Oceania Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 82: Oceania Market Volume (MT) Forecast by Source, 2018-2033
Table 83: Oceania Market Value (US$ Mn) Forecast by Form, 2018-2033
Table 84: Oceania Market Volume (MT) Forecast by Form, 2018-2033
Table 85: MEA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 86: MEA Market Volume (MT) Forecast by Country, 2018-2033
Table 87: MEA Market Value (US$ Mn) Forecast by Product Type, 2018-2033
Table 88: MEA Market Volume (MT) Forecast by Product Type, 2018-2033
Table 89: MEA Market Value (US$ Mn) Forecast by End Use Industry, 2018-2033
Table 90: MEA Market Volume (MT) Forecast by End Use Industry, 2018-2033
Table 91: MEA Market Value (US$ Mn) Forecast by Functionality, 2018-2033
Table 92: MEA Market Volume (MT) Forecast by Functionality, 2018-2033
Table 93: MEA Market Value (US$ Mn) Forecast by Source, 2018-2033
Table 94: MEA Market Volume (MT) Forecast by Source, 2018-2033
Table 95: MEA Market Value (US$ Mn) Forecast by Form, 2018-2033
Table 96: MEA Market Volume (MT) Forecast by Form, 2018-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) by Drug Type, 2023-2033
Figure 02: Global Market Value (US$ Mn) by Source, 2023-2033
Figure 03: Global Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 04: Global Market Value (US$ Mn) by Region, 2023-2033
Figure 05: Global Market Value (US$ Mn) Analysis by Region, 2018-2033
Figure 06: Global Market Volume (MT) Analysis by Region, 2018-2033
Figure 07: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 08: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 09: Global Market Value (US$ Mn) Analysis by Drug Type, 2018-2033
Figure 10: Global Market Volume (MT) Analysis by Drug Type, 2018-2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Drug Type, 2023-2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Drug Type, 2023-2033
Figure 13: Global Market Value (US$ Mn) Analysis by Source, 2018-2033
Figure 14: Global Market Volume (MT) Analysis by Source, 2018-2033
Figure 15: Global Market Value Share (%) and BPS Analysis by Source, 2023-2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by Source, 2023-2033
Figure 17: Global Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 18: Global Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 19: Global Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 20: Global Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 21: Global Market Attractiveness by Drug Type, 2023-2033
Figure 22: Global Market Attractiveness by Source, 2023-2033
Figure 23: Global Market Attractiveness by Sales Channel, 2023-2033
Figure 24: Global Market Attractiveness by Region, 2023-2033
Figure 25: North America Market Value (US$ Mn) by Drug Type, 2023-2033
Figure 26: North America Market Value (US$ Mn) by Source, 2023-2033
Figure 27: North America Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 28: North America Market Value (US$ Mn) by Country, 2023-2033
Figure 29: North America Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 30: North America Market Volume (MT) Analysis by Country, 2018-2033
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 33: North America Market Value (US$ Mn) Analysis by Drug Type, 2018-2033
Figure 34: North America Market Volume (MT) Analysis by Drug Type, 2018-2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Drug Type, 2023-2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Drug Type, 2023-2033
Figure 37: North America Market Value (US$ Mn) Analysis by Source, 2018-2033
Figure 38: North America Market Volume (MT) Analysis by Source, 2018-2033
Figure 39: North America Market Value Share (%) and BPS Analysis by Source, 2023-2033
Figure 40: North America Market Y-o-Y Growth (%) Projections by Source, 2023-2033
Figure 41: North America Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 42: North America Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 43: North America Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 44: North America Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 45: North America Market Attractiveness by Drug Type, 2023-2033
Figure 46: North America Market Attractiveness by Source, 2023-2033
Figure 47: North America Market Attractiveness by Sales Channel, 2023-2033
Figure 48: North America Market Attractiveness by Country, 2023-2033
Figure 49: Latin America Market Value (US$ Mn) by Drug Type, 2023-2033
Figure 50: Latin America Market Value (US$ Mn) by Source, 2023-2033
Figure 51: Latin America Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 52: Latin America Market Value (US$ Mn) by Country, 2023-2033
Figure 53: Latin America Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 54: Latin America Market Volume (MT) Analysis by Country, 2018-2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 57: Latin America Market Value (US$ Mn) Analysis by Drug Type, 2018-2033
Figure 58: Latin America Market Volume (MT) Analysis by Drug Type, 2018-2033
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Drug Type, 2023-2033
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Drug Type, 2023-2033
Figure 61: Latin America Market Value (US$ Mn) Analysis by Source, 2018-2033
Figure 62: Latin America Market Volume (MT) Analysis by Source, 2018-2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Source, 2023-2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Source, 2023-2033
Figure 65: Latin America Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 66: Latin America Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 67: Latin America Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 69: Latin America Market Attractiveness by Drug Type, 2023-2033
Figure 70: Latin America Market Attractiveness by Source, 2023-2033
Figure 71: Latin America Market Attractiveness by Sales Channel, 2023-2033
Figure 72: Latin America Market Attractiveness by Country, 2023-2033
Figure 73: Europe Market Value (US$ Mn) by Drug Type, 2023-2033
Figure 74: Europe Market Value (US$ Mn) by Source, 2023-2033
Figure 75: Europe Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 76: Europe Market Value (US$ Mn) by Country, 2023-2033
Figure 77: Europe Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 78: Europe Market Volume (MT) Analysis by Country, 2018-2033
Figure 79: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 80: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 81: Europe Market Value (US$ Mn) Analysis by Drug Type, 2018-2033
Figure 82: Europe Market Volume (MT) Analysis by Drug Type, 2018-2033
Figure 83: Europe Market Value Share (%) and BPS Analysis by Drug Type, 2023-2033
Figure 84: Europe Market Y-o-Y Growth (%) Projections by Drug Type, 2023-2033
Figure 85: Europe Market Value (US$ Mn) Analysis by Source, 2018-2033
Figure 86: Europe Market Volume (MT) Analysis by Source, 2018-2033
Figure 87: Europe Market Value Share (%) and BPS Analysis by Source, 2023-2033
Figure 88: Europe Market Y-o-Y Growth (%) Projections by Source, 2023-2033
Figure 89: Europe Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 90: Europe Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 91: Europe Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 93: Europe Market Attractiveness by Drug Type, 2023-2033
Figure 94: Europe Market Attractiveness by Source, 2023-2033
Figure 95: Europe Market Attractiveness by Sales Channel, 2023-2033
Figure 96: Europe Market Attractiveness by Country, 2023-2033
Figure 97: East Asia Market Value (US$ Mn) by Drug Type, 2023-2033
Figure 98: East Asia Market Value (US$ Mn) by Source, 2023-2033
Figure 99: East Asia Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 100: East Asia Market Value (US$ Mn) by Country, 2023-2033
Figure 101: East Asia Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 102: East Asia Market Volume (MT) Analysis by Country, 2018-2033
Figure 103: East Asia Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 104: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 105: East Asia Market Value (US$ Mn) Analysis by Drug Type, 2018-2033
Figure 106: East Asia Market Volume (MT) Analysis by Drug Type, 2018-2033
Figure 107: East Asia Market Value Share (%) and BPS Analysis by Drug Type, 2023-2033
Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Drug Type, 2023-2033
Figure 109: East Asia Market Value (US$ Mn) Analysis by Source, 2018-2033
Figure 110: East Asia Market Volume (MT) Analysis by Source, 2018-2033
Figure 111: East Asia Market Value Share (%) and BPS Analysis by Source, 2023-2033
Figure 112: East Asia Market Y-o-Y Growth (%) Projections by Source, 2023-2033
Figure 113: East Asia Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 114: East Asia Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 115: East Asia Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 116: East Asia Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 117: East Asia Market Attractiveness by Drug Type, 2023-2033
Figure 118: East Asia Market Attractiveness by Source, 2023-2033
Figure 119: East Asia Market Attractiveness by Sales Channel, 2023-2033
Figure 120: East Asia Market Attractiveness by Country, 2023-2033
Figure 121: South Asia Market Value (US$ Mn) by Drug Type, 2023-2033
Figure 122: South Asia Market Value (US$ Mn) by Source, 2023-2033
Figure 123: South Asia Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 124: South Asia Market Value (US$ Mn) by Country, 2023-2033
Figure 125: South Asia Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 126: South Asia Market Volume (MT) Analysis by Country, 2018-2033
Figure 127: South Asia Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 128: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 129: South Asia Market Value (US$ Mn) Analysis by Drug Type, 2018-2033
Figure 130: South Asia Market Volume (MT) Analysis by Drug Type, 2018-2033
Figure 131: South Asia Market Value Share (%) and BPS Analysis by Drug Type, 2023-2033
Figure 132: South Asia Market Y-o-Y Growth (%) Projections by Drug Type, 2023-2033
Figure 133: South Asia Market Value (US$ Mn) Analysis by Source, 2018-2033
Figure 134: South Asia Market Volume (MT) Analysis by Source, 2018-2033
Figure 135: South Asia Market Value Share (%) and BPS Analysis by Source, 2023-2033
Figure 136: South Asia Market Y-o-Y Growth (%) Projections by Source, 2023-2033
Figure 137: South Asia Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 138: South Asia Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 139: South Asia Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 140: South Asia Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 141: South Asia Market Attractiveness by Drug Type, 2023-2033
Figure 142: South Asia Market Attractiveness by Source, 2023-2033
Figure 143: South Asia Market Attractiveness by Sales Channel, 2023-2033
Figure 144: South Asia Market Attractiveness by Country, 2023-2033
Figure 145: Oceania Market Value (US$ Mn) by Drug Type, 2023-2033
Figure 146: Oceania Market Value (US$ Mn) by Source, 2023-2033
Figure 147: Oceania Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 148: Oceania Market Value (US$ Mn) by Country, 2023-2033
Figure 149: Oceania Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 150: Oceania Market Volume (MT) Analysis by Country, 2018-2033
Figure 151: Oceania Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 152: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 153: Oceania Market Value (US$ Mn) Analysis by Drug Type, 2018-2033
Figure 154: Oceania Market Volume (MT) Analysis by Drug Type, 2018-2033
Figure 155: Oceania Market Value Share (%) and BPS Analysis by Drug Type, 2023-2033
Figure 156: Oceania Market Y-o-Y Growth (%) Projections by Drug Type, 2023-2033
Figure 157: Oceania Market Value (US$ Mn) Analysis by Source, 2018-2033
Figure 158: Oceania Market Volume (MT) Analysis by Source, 2018-2033
Figure 159: Oceania Market Value Share (%) and BPS Analysis by Source, 2023-2033
Figure 160: Oceania Market Y-o-Y Growth (%) Projections by Source, 2023-2033
Figure 161: Oceania Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 162: Oceania Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 165: Oceania Market Attractiveness by Drug Type, 2023-2033
Figure 166: Oceania Market Attractiveness by Source, 2023-2033
Figure 167: Oceania Market Attractiveness by Sales Channel, 2023-2033
Figure 168: Oceania Market Attractiveness by Country, 2023-2033
Figure 169: MEA Market Value (US$ Mn) by Drug Type, 2023-2033
Figure 170: MEA Market Value (US$ Mn) by Source, 2023-2033
Figure 171: MEA Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 172: MEA Market Value (US$ Mn) by Country, 2023-2033
Figure 173: MEA Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 174: MEA Market Volume (MT) Analysis by Country, 2018-2033
Figure 175: MEA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 176: MEA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 177: MEA Market Value (US$ Mn) Analysis by Drug Type, 2018-2033
Figure 178: MEA Market Volume (MT) Analysis by Drug Type, 2018-2033
Figure 179: MEA Market Value Share (%) and BPS Analysis by Drug Type, 2023-2033
Figure 180: MEA Market Y-o-Y Growth (%) Projections by Drug Type, 2023-2033
Figure 181: MEA Market Value (US$ Mn) Analysis by Source, 2018-2033
Figure 182: MEA Market Volume (MT) Analysis by Source, 2018-2033
Figure 183: MEA Market Value Share (%) and BPS Analysis by Source, 2023-2033
Figure 184: MEA Market Y-o-Y Growth (%) Projections by Source, 2023-2033
Figure 185: MEA Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 186: MEA Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 187: MEA Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 188: MEA Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 189: MEA Market Attractiveness by Drug Type, 2023-2033
Figure 190: MEA Market Attractiveness by Source, 2023-2033
Figure 191: MEA Market Attractiveness by Sales Channel, 2023-2033
Figure 192: MEA Market Attractiveness by Country, 2023-2033
Figure 211: MEA Market Value (US$ Mn) by Active Compounds, 2023-2033
Figure 212: MEA Market Value (US$ Mn) by Product Type, 2023-2033
Figure 213: MEA Market Value (US$ Mn) by Form, 2023-2033
Figure 214: MEA Market Value (US$ Mn) by Sales Channel, 2023-2033
Figure 215: MEA Market Value (US$ Mn) by Country, 2023-2033
Figure 216: MEA Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 217: MEA Market Volume (MT) Analysis by Country, 2018-2033
Figure 218: MEA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 219: MEA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 220: MEA Market Value (US$ Mn) Analysis by Active Compounds, 2018-2033
Figure 221: MEA Market Volume (MT) Analysis by Active Compounds, 2018-2033
Figure 222: MEA Market Value Share (%) and BPS Analysis by Active Compounds, 2023-2033
Figure 223: MEA Market Y-o-Y Growth (%) Projections by Active Compounds, 2023-2033
Figure 224: MEA Market Value (US$ Mn) Analysis by Product Type, 2018-2033
Figure 225: MEA Market Volume (MT) Analysis by Product Type, 2018-2033
Figure 226: MEA Market Value Share (%) and BPS Analysis by Product Type, 2023-2033
Figure 227: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2023-2033
Figure 228: MEA Market Value (US$ Mn) Analysis by Form, 2018-2033
Figure 229: MEA Market Volume (MT) Analysis by Form, 2018-2033
Figure 230: MEA Market Value Share (%) and BPS Analysis by Form, 2023-2033
Figure 231: MEA Market Y-o-Y Growth (%) Projections by Form, 2023-2033
Figure 232: MEA Market Value (US$ Mn) Analysis by Sales Channel, 2018-2033
Figure 233: MEA Market Volume (MT) Analysis by Sales Channel, 2018-2033
Figure 234: MEA Market Value Share (%) and BPS Analysis by Sales Channel, 2023-2033
Figure 235: MEA Market Y-o-Y Growth (%) Projections by Sales Channel, 2023-2033
Figure 236: MEA Market Attractiveness by Active Compounds, 2023-2033
Figure 237: MEA Market Attractiveness by Product Type, 2023-2033
Figure 238: MEA Market Attractiveness by Form, 2023-2033
Figure 239: MEA Market Attractiveness by Sales Channel, 2023-2033
Figure 240: MEA Market Attractiveness by Country, 2023-2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the global Marine-derived Pharmaceuticals industry?
The Marine-derived Pharmaceuticals market is estimated to reach a valuation of about US$ 4,131.3 million in 2023.
How big is the United States Marine-derived Pharmaceuticals industry?
The Marine-derived Pharmaceuticals market is estimated to reach a valuation of about US$ 838.7 million in 2023.
What is the growth projection for the worldwide Marine-derived Pharmaceuticals industry by 2033?
The global Marine-derived Pharmaceuticals market value is projected to reach US$ 9,083.1 million by 2033.
At what rate is global demand for Marine-derived Pharmaceuticals expected to increase from 2023 to 2033?
Global Marine-derived Pharmaceuticals demand is expected to increase at a CAGR of around 8.2% through 2033.
What Marine source is in high demand as an ideal source of Marine-derived pharmaceutical products?
One of the most sought-after sources in marine-derived pharmaceuticals is marine sponges. Marine sponges have been recognized as a rich source of bioactive compounds with diverse chemical structures and potent pharmacological activities.
What was the historical CAGR for the Marine-derived Pharmaceuticals Market?
Global demand for Marine-derived Pharmaceuticals registered a CAGR of 7.5% historically, from 2018 to 2022.
What components of Shark Cartilage make it an ideal source for the Marine-derived Pharmaceuticals Market?
Shark cartilage is primarily composed of proteins, glycosaminoglycans (such as chondroitin sulfate), and calcium salts. It also contains other bioactive components, including small peptides, lectins, and growth factors, which makes it an ideal source for
Marine-derived Pharmaceuticals Market